These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

137 related articles for article (PubMed ID: 38734319)

  • 21. Interaction between prostate cancer cells and prostate fibroblasts promotes accumulation and proteolytic processing of basement membrane proteins.
    Ojalill M; Virtanen N; Rappu P; Siljamäki E; Taimen P; Heino J
    Prostate; 2020 Jun; 80(9):715-726. PubMed ID: 32364250
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Metabolic reprogramming of normal oral fibroblasts correlated with increased glycolytic metabolism of oral squamous cell carcinoma and precedes their activation into carcinoma associated fibroblasts.
    Zhang Z; Gao Z; Rajthala S; Sapkota D; Dongre H; Parajuli H; Suliman S; Das R; Li L; Bindoff LA; Costea DE; Liang X
    Cell Mol Life Sci; 2020 Mar; 77(6):1115-1133. PubMed ID: 31270582
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Elevated epithelial expression of interleukin-8 correlates with myofibroblast reactive stroma in benign prostatic hyperplasia.
    Schauer IG; Ressler SJ; Tuxhorn JA; Dang TD; Rowley DR
    Urology; 2008 Jul; 72(1):205-13. PubMed ID: 18314176
    [TBL] [Abstract][Full Text] [Related]  

  • 24. The impact of stromal Hic-5 on the tumorigenesis of colorectal cancer through lysyl oxidase induction and stromal remodeling.
    Omoto T; Kim-Kaneyama JR; Lei XF; Orimo A; Ohnishi K; Yoshihara K; Miyauchi A; Li S; Gao L; Umemoto T; Tanaka J; Nakahara K; Takeya M; Ishida F; Kudo SE; Haraguchi S; Miyazaki T; Miyazaki A
    Oncogene; 2018 Mar; 37(9):1205-1219. PubMed ID: 29242607
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Metabolic reprogramming and crosstalk of cancer-related fibroblasts and immune cells in the tumor microenvironment.
    Zhu Y; Li X; Wang L; Hong X; Yang J
    Front Endocrinol (Lausanne); 2022; 13():988295. PubMed ID: 36046791
    [TBL] [Abstract][Full Text] [Related]  

  • 26. A lactate shuttle system between tumour and stromal cells is associated with poor prognosis in prostate cancer.
    Pértega-Gomes N; Vizcaíno JR; Attig J; Jurmeister S; Lopes C; Baltazar F
    BMC Cancer; 2014 May; 14():352. PubMed ID: 24886074
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Cancer-associated fibroblasts promote prostate cancer malignancy via metabolic rewiring and mitochondrial transfer.
    Ippolito L; Morandi A; Taddei ML; Parri M; Comito G; Iscaro A; Raspollini MR; Magherini F; Rapizzi E; Masquelier J; Muccioli GG; Sonveaux P; Chiarugi P; Giannoni E
    Oncogene; 2019 Jul; 38(27):5339-5355. PubMed ID: 30936458
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Protocols for Studies on Stromal Cells in Prostate Cancer.
    Leach DA; Buchanan G
    Methods Mol Biol; 2018; 1786():207-218. PubMed ID: 29786795
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Inhibition of Nox4-dependent ROS signaling attenuates prostate fibroblast activation and abrogates stromal-mediated protumorigenic interactions.
    Sampson N; Brunner E; Weber A; Puhr M; Schäfer G; Szyndralewiez C; Klocker H
    Int J Cancer; 2018 Jul; 143(2):383-395. PubMed ID: 29441570
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Rapid selection of mesenchymal stem and progenitor cells in primary prostate stromal cultures.
    Brennen WN; Kisteman LN; Isaacs JT
    Prostate; 2016 May; 76(6):552-64. PubMed ID: 26732992
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Alterations in the methylome of the stromal tumour microenvironment signal the presence and severity of prostate cancer.
    Lawrence MG; Pidsley R; Niranjan B; Papargiris M; Pereira BA; Richards M; Teng L; Norden S; Ryan A; Frydenberg M; Stirzaker C; Taylor RA; Risbridger GP; Clark SJ
    Clin Epigenetics; 2020 Mar; 12(1):48. PubMed ID: 32188493
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Metabolic reprogramming of cancer-associated fibroblasts by TGF-β drives tumor growth: connecting TGF-β signaling with "Warburg-like" cancer metabolism and L-lactate production.
    Guido C; Whitaker-Menezes D; Capparelli C; Balliet R; Lin Z; Pestell RG; Howell A; Aquila S; Andò S; Martinez-Outschoorn U; Sotgia F; Lisanti MP
    Cell Cycle; 2012 Aug; 11(16):3019-35. PubMed ID: 22874531
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Novel Therapeutic Targets and Biomarkers Associated with Prostate Cancer-Associated Fibroblasts (CAFs).
    Clark KC; Wu Y; Taylor RA; Daly RJ
    Crit Rev Oncog; 2022; 27(1):1-24. PubMed ID: 35993976
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Unbiased differential proteomic profiling between cancer-associated fibroblasts and cancer cell lines.
    Lau R; Yu L; Roumeliotis TI; Stewart A; Pickard L; Riisanes R; Gurel B; de Bono JS; Choudhary JS; Banerji U
    J Proteomics; 2023 Sep; 288():104973. PubMed ID: 37481068
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Repositioning of antiarrhythmics for prostate cancer treatment: a novel strategy to reprogram cancer-associated fibroblasts towards a tumor-suppressive phenotype.
    Doldi V; Tortoreto M; Colecchia M; Maffezzini M; Percio S; Giammello F; Brandalise F; Gandellini P; Zaffaroni N
    J Exp Clin Cancer Res; 2024 Jun; 43(1):161. PubMed ID: 38858661
    [TBL] [Abstract][Full Text] [Related]  

  • 36. YAP1 plays a key role of the conversion of normal fibroblasts into cancer-associated fibroblasts that contribute to prostate cancer progression.
    Shen T; Li Y; Zhu S; Yu J; Zhang B; Chen X; Zhang Z; Ma Y; Niu Y; Shang Z
    J Exp Clin Cancer Res; 2020 Feb; 39(1):36. PubMed ID: 32066485
    [TBL] [Abstract][Full Text] [Related]  

  • 37. A bioengineered microenvironment to quantitatively measure the tumorigenic properties of cancer-associated fibroblasts in human prostate cancer.
    Clark AK; Taubenberger AV; Taylor RA; Niranjan B; Chea ZY; Zotenko E; Sieh S; Pedersen JS; Norden S; Frydenberg M; Grummet JP; Pook DW; ; Stirzaker C; Clark SJ; Lawrence MG; Ellem SJ; Hutmacher DW; Risbridger GP
    Biomaterials; 2013 Jul; 34(20):4777-85. PubMed ID: 23562048
    [TBL] [Abstract][Full Text] [Related]  

  • 38. A reciprocal role of prostate cancer on stromal DNA damage.
    Banerjee J; Mishra R; Li X; Jackson RS; Sharma A; Bhowmick NA
    Oncogene; 2014 Oct; 33(41):4924-31. PubMed ID: 24141771
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Targeting the tumor stroma as a novel therapeutic approach for prostate cancer.
    Franco OE; Hayward SW
    Adv Pharmacol; 2012; 65():267-313. PubMed ID: 22959029
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Cross-talk between paracrine-acting cytokine and chemokine pathways promotes malignancy in benign human prostatic epithelium.
    Ao M; Franco OE; Park D; Raman D; Williams K; Hayward SW
    Cancer Res; 2007 May; 67(9):4244-53. PubMed ID: 17483336
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.